Overview of Dr. Wenham
Dr. Robert Wenham is an oncologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. He received his medical degree from University of Texas Southwestern Medical School and has been in practice 20 years. Dr. Wenham accepts several types of health insurance, listed below. He is one of 170 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Oncology. He has more than 100 publications and over 500 citings.
Office
12902 Usf Magnolia Dr
Tampa, FL 33612
Education & Training
- Duke University HospitalFellowship, Gynecologic Oncology, 2004
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolInternship, Obstetrics and Gynecology, 1997 - 2001
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Obstetrics and Gynecology, 2001
- University of Texas Southwestern Medical SchoolClass of 1997
Certifications & Licensure
- FL State Medical License 2004 - 2025
- NC State Medical License 2001 - 2014
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Super Doctor SuperDoctors.com
- Fellow (FACS) American College of Surgeons
- Join now to see all
Clinical Trials
- Vorinostat and Doxorubicin in Treating Patients With Metastatic or Locally Advanced Solid Tumors Start of enrollment: 2006 Mar 01
- Phase I Study of Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Subjects With Metastatic Cancer Start of enrollment: 2006 Apr 01
- Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma Start of enrollment: 2007 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 405 citationsThe poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trialShahneen Sandhu, William R. Schelman, George Wilding, Victor Moreno, Richard D. Baird
The Lancet. Oncology. 2013-08-01 - 20 citationsHigh-dose intensity-modulated chemoradiotherapy in vulvar squamous cell carcinoma: Outcome and toxicity.Anupam Rishi, Madeline Rollins, Kamran Ahmed, Dylan C. Hunt, Papri Sarkar
Gynecologic Oncology. 2020-02-01 - 112 citationsIgA transcytosis and antigen recognition govern ovarian cancer immunity.Subir Biswas, Gunjan Mandal, Kyle K. Payne, Carmen M. Anadon, Chandler Gatenbee
Nature. 2021-02-03
Press Mentions
- Anixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical TrialOctober 15th, 2024
- Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T TrialSeptember 30th, 2024
- ‘Our Hero’: 2-Year-Old Georgia Girl Diagnosed with Rare Ovarian CancerMarch 10th, 2019
- Join now to see all
Professional Memberships
- Fellow
- Member
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
AvMed Health Open Access
BCBS Blue Card PPO
BCBS Florida BlueCare HMO
BCBS Florida NetworkBlue
BCBS Florida Preferred Patient Care PPO
CIGNA HMO
CIGNA Open AccessCIGNA PPO
Coventry Florida - Employer Group PPO
First Health PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: